Cargando…

MCM10 overexpression implicates adverse prognosis in urothelial carcinoma

Urothelial carcinoma (UC) occurs in the upper urinary tract (UTUC) and the urinary bladder (UBUC). The molecular pathogenesis of UC has not been fully elucidated. Through data mining of a published transcriptome of UBUC (GSE31684), we identified Minichromosome Maintenance Complex Component 2 (MCM2)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wei-Ming, Huang, Chun-Nung, Ke, Hung-Lung, Li, Ching-Chia, Wei, Yu-Ching, Yeh, Hsin-Chih, Chang, Lin-Li, Huang, Chun-Hsiung, Liang, Peir-In, Yeh, Bi-Wen, Chan, Ti-Chun, Li, Chien-Feng, Wu, Wen-Jeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363620/ https://www.ncbi.nlm.nih.gov/pubmed/27780919 http://dx.doi.org/10.18632/oncotarget.12795

Ejemplares similares

DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness
por: Liang, Peir-In, et al.
Publicado: (2016)

DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study
por: Tsai, Meng-Chen, et al.
Publicado: (2016)

Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract
por: Lee, Hsiang-Ying, et al.
Publicado: (2017)

CSF2 Overexpression Is Associated with STAT5 Phosphorylation and Poor Prognosis in Patients with Urothelial Carcinoma
por: Lee, Yi-Ying, et al.
Publicado: (2016)

Role of Microtubule-Associated Protein 1b in Urothelial Carcinoma: Overexpression Predicts Poor Prognosis
por: Chien, Tsu-Ming, et al.
Publicado: (2020)

Hypoxia-regulated MicroRNA-210 Overexpression is Associated with Tumor Development and Progression in Upper Tract Urothelial Carcinoma
por: Ke, Hung-Lung, et al.
Publicado: (2017)

Identification of potential genes in upper tract urothelial carcinoma using next-generation sequencing with bioinformatics and in vitro analyses
por: Lee, Hsiang-Ying, et al.
Publicado: (2021)

The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence
por: Lee, Hsiang-Ying, et al.
Publicado: (2018)

Concurrent Preoperative Presence of Hydronephrosis and Flank Pain Independently Predicts Worse Outcome of Upper Tract Urothelial Carcinoma
por: Yeh, Hsin-Chih, et al.
Publicado: (2015)

High Expression of 17β-hydroxysteroid Dehydrogenase Type 2 is Associated with a Better Prognosis in Urothelial Carcinoma of the Urinary Tract
por: Wang, Chieh-Tien, et al.
Publicado: (2016)

Prognostic Utility of FBLN2 Expression in Patients With Urothelial Carcinoma
por: Li, Wei-Ming, et al.
Publicado: (2020)

Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder
por: Lee, Yi-Ying, et al.
Publicado: (2016)

Complement Component 1, s Subcomponent Overexpression is an Independent Poor Prognostic Indicator in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder
por: Chang, I-Wei, et al.
Publicado: (2016)

Deduction of Novel Genes Potentially Involved in Upper Tract Urothelial Carcinoma Using Next-Generation Sequencing and Bioinformatics Approaches
por: Lee, Hsiang-Ying, et al.
Publicado: (2019)

Prognostic Significance of ROR2 Expression in Patients with Urothelial Carcinoma
por: Yeh, Cheng-Fa, et al.
Publicado: (2021)

Prognostic Impact of Thrombospodin-2 (THBS2) Overexpression on Patients with Urothelial Carcinomas of Upper Urinary Tracts and Bladders
por: Chang, I-Wei, et al.
Publicado: (2016)

Over-expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma
por: Li, Wei-Ming, et al.
Publicado: (2017)

Necdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder
por: Chang, I-Wei, et al.
Publicado: (2016)

CEBPD amplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosis
por: Wang, Yu-Hui, et al.
Publicado: (2015)

CSF-1 Overexpression Predicts Poor Prognosis in Upper Tract Urothelial Carcinomas
por: Hsu, Wei-Chi, et al.
Publicado: (2019)

Utility of EFEMP1 in the Prediction of Oncologic Outcomes of Urothelial Carcinoma
por: Chen, Tzu-Ju, et al.
Publicado: (2021)

Prognostic Factors for Contralateral Recurrence of Upper Tract Urothelial Carcinoma after Nephroureterectomy: A Large Multiregional Study
por: Chien, Tsu-Ming, et al.
Publicado: (2021)

Prognostic Value of Comorbidity for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy
por: Ke, Hung-Lung, et al.
Publicado: (2022)

Validation of Hyponatremia as a Prognostic Predictor in Multiregional Upper Tract Urothelial Carcinoma
por: Yeh, Hsin-Chih, et al.
Publicado: (2020)

Low Hemoglobin-to-Red Cell Distribution Width Ratio Is Associated with Disease Progression and Poor Prognosis in Upper Tract Urothelial Carcinoma
por: Su, Yung-Chun, et al.
Publicado: (2021)

SERPINE2 Overexpression Is Associated with Poor Prognosis of Urothelial Carcinoma
por: Chuang, Hao-Wen, et al.
Publicado: (2021)

Overexpression of Pyruvate Dehydrogenase Kinase-3 Predicts Poor Prognosis in Urothelial Carcinoma
por: Kuo, Yu-Hsuan, et al.
Publicado: (2021)

Predominant global glomerulosclerosis in patients of upper urinary tract urothelial carcinoma with pre-existing renal function impairment is a predictor of poor renal outcomes
por: Niu, Sheng-Wen, et al.
Publicado: (2019)

SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma
por: Ma, Li-Jung, et al.
Publicado: (2016)

How to manage patients with suspected upper tract urothelial carcinoma in the pandemic of COVID-19?
por: Lee, Hsiang-Ying, et al.
Publicado: (2021)

CTSE Overexpression Is an Adverse Prognostic Factor for Survival among Rectal Cancer Patients Receiving CCRT
por: Chou, Chia-Lin, et al.
Publicado: (2021)

Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma
por: Liang, Peir-In, et al.
Publicado: (2023)

SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma
por: Chan, Ti-Chun, et al.
Publicado: (2020)

The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma
por: Li, Chien-Feng, et al.
Publicado: (2015)

Development and validation of a nomogram for urothelial cancer in patients with chronic kidney disease
por: Chou, Che-Yi, et al.
Publicado: (2019)

High Stromal SFRP2 Expression in Urothelial Carcinoma Confers an Unfavorable Prognosis
por: Lai, Hong-Yue, et al.
Publicado: (2022)

Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma
por: Wu, Wen-Ren, et al.
Publicado: (2020)

The biological impacts of CEBPD on urothelial carcinoma development and progression
por: Chan, Ti-Chun, et al.
Publicado: (2023)

HuR cytoplasmic expression is associated with increased cyclin A expression and poor outcome with upper urinary tract urothelial carcinoma
por: Liang, Peir-In, et al.
Publicado: (2012)

5α-reductase inhibitors impact prognosis of urothelial carcinoma
por: Wang, Chien-Sheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_642i26d3t1678neomhtqu675kk